These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7620005)

  • 1. Characteristics of and risk factors for relapse of brucellosis in humans.
    Ariza J; Corredoira J; Pallares R; Viladrich PF; Rufi G; Pujol M; Gudiol F
    Clin Infect Dis; 1995 May; 20(5):1241-9. PubMed ID: 7620005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic cutaneous lesions in patients with brucellosis.
    Ariza J; Servitje O; Pallarés R; Fernández Viladrich P; Rufí G; Peyrí J; Gudiol F
    Arch Dermatol; 1989 Mar; 125(3):380-3. PubMed ID: 2923445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis.
    Navarro E; Segura JC; Castaño MJ; Solera J
    Clin Infect Dis; 2006 May; 42(9):1266-73. PubMed ID: 16586386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age and duration of disease on the clinical manifestations of brucellosis. A study of 73 consecutive patients in Israel.
    Yinnon AM; Morali GA; Goren A; Rudensky B; Isacsohn M; Michel J; Hershko C
    Isr J Med Sci; 1993 Jan; 29(1):11-6. PubMed ID: 8454438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood brucellosis--a microbiological, epidemiological and clinical study.
    Mantur BG; Akki AS; Mangalgi SS; Patil SV; Gobbur RH; Peerapur BV
    J Trop Pediatr; 2004 Jun; 50(3):153-7. PubMed ID: 15233191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Relapse of Human Brucellosis.
    Hasanjani Roushan MR; Moulana Z; Mohseni Afshar Z; Ebrahimpour S
    Glob J Health Sci; 2015 Nov; 8(7):77-82. PubMed ID: 26925907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucellosis in central Anatolia: evaluation of complications and relapse.
    Naz H; Aykin N; Cevik F; Bal C
    Trop Doct; 2009 Apr; 39(2):107-9. PubMed ID: 19299298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucella melitensis bacteremia in children: review of 62 cases.
    Almuneef M; Memish ZA; Al Shaalan M; Al Banyan E; Al-Alola S; Balkhy HH
    J Chemother; 2003 Feb; 15(1):76-80. PubMed ID: 12678419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections.
    al-Sibai MB; Halim MA; el-Shaker MM; Khan BA; Qadri SM
    Antimicrob Agents Chemother; 1992 Jan; 36(1):150-2. PubMed ID: 1590681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brucellosis: do we need to revise our therapeutic policy?
    El Miedany YM; El Gaafary M; Baddour M; Ahmed I
    J Rheumatol; 2003 Dec; 30(12):2666-72. PubMed ID: 14719211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucellosis in cases of end-stage renal disease.
    Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Timurkaynak F; Ozdemir N; Arslan H
    Nephrol Dial Transplant; 2008 Jul; 23(7):2344-9. PubMed ID: 18178600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucellosis: a retrospective evaluation.
    Tasbakan MI; Yamazhan T; Gökengin D; Arda B; Sertpolat M; Ulusoy S; Ertem E; Demir S
    Trop Doct; 2003 Jul; 33(3):151-3. PubMed ID: 12875250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of recent and relapsed cases of human brucellosis by PCR assay.
    Nimri LF
    BMC Infect Dis; 2003 Apr; 3():5. PubMed ID: 12718759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
    Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
    Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran.
    Mohammadbeigi A; Saghafipour A; Hamta A; Khazaei S; Maghsoudi A; Shams S
    Ghana Med J; 2021 Sep; 55(3):206-212. PubMed ID: 35950176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic brucellosis: a rare cause of septic loosening of arthroplasties with high risk of laboratory-acquired infections].
    Wünschel M; Olszowski AM; Weissgerber P; Wülker N; Kluba T
    Z Orthop Unfall; 2011 Jan; 149(1):33-6. PubMed ID: 20419627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.
    Solera J; Geijo P; Largo J; Rodriguez-Zapata M; Gijón J; Martinez-Alfaro E; Navarro E; Macia MA;
    Clin Infect Dis; 2004 Dec; 39(12):1776-82. PubMed ID: 15578399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteremia is as unpredictable as clinical manifestations in human brucellosis.
    Mantur BG; Mulimani MS; Bidari LH; Akki AS; Tikare NV
    Int J Infect Dis; 2008 May; 12(3):303-7. PubMed ID: 18023384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver histology of acute brucellosis caused by Brucella melitensis.
    Young EJ; Hasanjani Roushan MR; Shafae S; Genta RM; Taylor SL
    Hum Pathol; 2014 Oct; 45(10):2023-8. PubMed ID: 25147098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucellosis treated with rifampicin.
    Llorens-Terol J; Busquets RM
    Arch Dis Child; 1980 Jun; 55(6):486-8. PubMed ID: 7436494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.